Niti Aayog working on blockchain tech for drug industry
Niti Aayog is working with Apollo Hospitals and information technology major Oracle on applying blockchain technology in pharmaceutical supply chain management to detect spurious drugs, informed NITI Aayog’s CEO, Mr. Amitabh Kant.
Addressing a gathering through video-conferencing at the inaugural session of International Blockchain Congress 2018 held in Hyderabad recently, Mr. Kant said the organisation was working on applying the blockchain technology to pressing problems of the country in areas such as land registry, health records and fertiliser subsidy distribution, among others.
“There is a need to use blockchain to track and trace medicines and spurious drugs. Therefore, Niti Aayog, in collaboration with Apollo Hospitals and Oracle, is putting pharmaceutical supply chain in blockchain for complete traceability of drugs from manufacturer to consumer to protect our citizens from the menace of spurious medicines,” he said.
2026-10-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
TSMC, Samsung, and SK Hynix Scramble for Electronic-Grade Hydrofluoric Acid as High-End Supply Tightens; Some Suppliers Raise Prices by 30% This Year
-
“Amputation or Strategic Retreat?”: Shell’s Six-Year Chemical Losses and the Quiet Unwinding of an Empire
-
Tinci Materials Calls Off 2.65 Billion Yuan Project as Electrolyte Giant Shifts Strategy
-
“The 40-Year Ethylene Giant Collapses”: ExxonMobil’s Premature Shutdown Is Not Just Scotland’s Tragedy—It’s the Twilight Elegy of European Industrial Civilization
-
Eastern Shenghong Projects First-Half Profit of 5 Billion Yuan – A Collective Turnaround for the Four Major Private Refiners? Is the Chemical Sector Rebounding?
-
U.S.-Iran Détente Triggers Oil Price Plunge, Energy and Chemical Sectors Tumble
-
Sulfur Price Hits 7,633 CNY/Ton, Up Nearly Sixfold in a Year and a Half; Domestic Refining Giants Halt New Orders Due to Tight Supply
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
-
Obesity Drugs Become Pharma’s Most Powerful Growth Engine
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
Recommend Reading
-
UAE Withdraws from OPEC
-
Indonesia’s Plastic Prices Jump 50%–100% as Government Moves to Remove Import Duties
-
Butadiene Rubber's Cost in China Floor Collapses, Exports Hold the Line
-
China’s Titanium Dioxide Giant Makes a Move: LB Group Acquires UK Venator Assets
-
Japanese Plastics Market Accelerates its Shifts to Recycled Materials and Bioplastics
-
Heptane: Properties, Uses, and Industrial Applications
-
Business Society’s Market Outlook for Maleic Anhydride on August 18, 2026: Volatile
-
Business Society October 12, 2026 Fuel Oil 180CST Trend Analysis: Volatility
-
HNO2 (Nitrous Acid): Properties, Uses, and Safety
-
Business Society’s Toluene Market Outlook on August 19, 2026: Volatile